Clinical and Molecular Microbiology Director - Northern Light Laboratory, Bangor, ME
BIOGRAPHY
APR 09, 2021 9:00 AM PDT
Implementation of a Multiplex Molecular Test for Anaplasma, Babesia and Ehrlichia
Speaker
Event Date & Time
Date: April 9, 2021
Time: 9:00am PDT, 11:00am EDT
Abstract
There are tick-borne diseases beyond what causes Lyme disease. Different geographies have differing prevalence’s of tick-borne infections. In the northeastern USA, some of the other infectious agents are Anaplasma phagocytophilum, Babesia species and Ehrlichia species. This talk will describe our experiences on the processes used to implement a multiplex molecular laboratory developed test (LDT) for the detection of A. phagocytophilum, Babesia spp. and Ehrlichia spp. in a clinical reference laboratory. We will discuss various testing options including assay types and ordering algorithms. Our experiences and lessons learned after implementation will be discussed, including the testing challenges we had related to COVID-19.
Learning Objectives:
- Describe the various methods available for detection of Anaplasma, Babesia and Ehrlichia
- Understand the process of LDT validation
- Discuss advantages and limitations of in-house testing
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
Loading Comments...